Gene · 6752
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Extra-Axial Cavernous Angioma: A Case Report and Review of the Literature. | Neurol Int | 2024 | 38251058 | PubTator, text mining | PubMed |
| Peptide receptor radionuclide therapy combinations for neuroendocrine tumours in ongoing clinical trials: status 2023. | Theranostics | 2024 | 38250038 | PubTator, text mining | PubMed |
| Molecular imaging for evaluation of synovitis associated with osteoarthritis: a narrative review. | Arthritis Res Ther | 2024 | 38229205 | PubTator, text mining | PubMed |
| Rare post-operative intracranial abscess due to Serratia marcescens: what we can learn from it? | BMC Infect Dis | 2024 | 38191337 | PubTator, text mining | PubMed |
| Effect of mitotane in patients with ectopic adrenocorticotropic hormone syndrome caused by advanced pancreatic neuroendocrine tumors: a case series and review of the literature. | J Int Med Res | 2024 | 38190848 | PubTator, text mining | PubMed |
| CardiOmics signatures reveal therapeutically actionable targets and drugs for cardiovascular diseases. | Heliyon | 2024 | 38187312 | PubTator, text mining | PubMed |
| Design, Preclinical Evaluation, and Clinical Translation of 68Ga-FAPI-LM3, a Heterobivalent Molecule for PET Imaging of Nasopharyngeal Carcinoma. | J Nucl Med | 2024 | 38176714 | PubTator, text mining | PubMed |
| [Practical application of immunohistochemistry in pancreatic neuroendocrine neoplasms : Tips and pitfalls]. | Pathologie (Heidelb) | 2024 | 38175232 | PubTator, text mining | PubMed |
The value of color doppler ultrasonography combined with computed tomography angiography and magnetic resonance angiography in the preoperative quantification and classification of carotid body tumors: a retrospective analysis. | BMC Med Imaging | 2024 | 38172706 | PubTator, text mining | PubMed |
| Long-term Nephrotoxicity after PRRT: Myth or Reality. | Theranostics | 2024 | 38169589 | PubTator, text mining | PubMed |
| CNKSR2 expression is correlated with immune infiltrates in Cervical Cancer as a favorable prognostic factor. | J Cancer | 2024 | 38169557 | PubTator, text mining | PubMed |
| Improving susceptibility of neuroendocrine tumors to radionuclide therapies: personalized approaches towards complementary treatments. | Theranostics | 2024 | 38164150 | PubTator, text mining | PubMed |
| FDA-approved heterocyclic molecules for cancer treatment: Synthesis, dosage, mechanism of action and their adverse effect. | Heliyon | 2024 | 38163206 | PubTator, text mining | PubMed |
| Diagnosis of pancreatic focal nesidioblastosis assisted by dual‑nuclide tracer positron emission tomography/computed tomography: A case report. | Exp Ther Med | 2024 | 38125355 | PubTator, text mining | PubMed |
| A novel somatostatin receptor ligand for human ACTH - and GH -secreting pituitary adenomas. | Eur J Endocrinol | 2024 | 38123488 | PubTator, text mining | PubMed |
| Using AlphaFold and Experimental Structures for the Prediction of the Structure and Binding Affinities of GPCR Complexes via Induced Fit Docking and Free Energy Perturbation. | J Chem Theory Comput | 2024 | 38100422 | PubTator, text mining | PubMed |
| Pituitary apoplexy in endocrinologically silent adenoma during somatostatin analog administration for pancreatic neuroendocrine tumor: A case report. | Neuropathology | 2024 | 38099404 | PubTator, text mining | PubMed |
| Biomarkers of response to treatment in acromegaly. | Expert Rev Endocrinol Metab | 2024 | 38078447 | PubTator, text mining | PubMed |
| Evaluation of the SSTR2-targeted Radiopharmaceutical 177Lu-DOTATATE and SSTR2-specific 68Ga-DOTATATE PET as Imaging Biomarker in Patients with Intracranial Meningioma. | Clin Cancer Res | 2024 | 38048045 | PubTator, text mining | PubMed |
| Somatostatin receptor2 (SSTR2) expression, prognostic implications, modifications and potential therapeutic strategies associates with head and neck squamous cell carcinomas. | Crit Rev Oncol Hematol | 2024 | 38036157 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6752/papers?page=17